Publication

Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations

Journal Paper/Review - Feb 9, 2016

Units
PubMed
Doi

Citation
Konstantinova A, Guenova E, Kerl K, Zamecnik M, Danis D, Bisceglia M, Shelekhova K, Hejda V, Denisjuk N, Plaza J, Zelger B, Kutzner H, Stewart C, Spagnolo D, Kacerovska D, Michal M, Kazakov D. Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations. Am J Dermatopathol 2016
Type
Journal Paper/Review (English)
Journal
Am J Dermatopathol 2016
Publication Date
Feb 9, 2016
Issn Electronic
1533-0311
Brief description/objective

UNASSIGNED
Hidradenoma papilliferum (HP), also known as papillary hidradenoma, is the most common benign lesion of the female anogenital area derived from anogenital mammary-like glands (AGMLG). HP can be viewed conceptually as the cutaneous counterpart of mammary intraductal papilloma. The authors have studied 264 cases of HP, detailing various changes in the tumor and adjacent AGMLG, with emphasis on mammary-type alterations. In many HP, the authors noticed changes typical for benign breast lesions, such as sclerosing adenosis-like changes, usual, and atypical ductal hyperplasia. Almost in a third of cases, remnants of AGMLG adjacent to the lesion were evident, manifesting columnar changes reminiscent of those seen in breast lesions. This study shows that the histopathological changes in HP run a broad spectrum comparable with that in the mammary counterpart and benign breast disease.